Akshay Vaishnaw, President at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 76,088 shares at $213.13 ($16.4M) on 2023-02-10, disclosed to the SEC on 2023-02-14.
Open-market sale of $16.4M ALNY by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $213.13 | 1,709 | $364K | 2.2% |
| 2 | $213.13 | 1,709 | $364K | 2.2% |
| 3 | $214.28 | 2,307 | $494K | 3.0% |
| 4 | $214.28 | 2,307 | $494K | 3.0% |
| 5 | $215.59 | 10,279 | $2.2M | 13.5% |
| 6 | $215.59 | 10,279 |
| $2.2M |
| 13.5% |
| 7 | $216.38 | 19,447 | $4.2M | 25.6% |
| 8 | $216.38 | 19,447 | $4.2M | 25.6% |
| 9 | $217.05 | 4,302 | $934K | 5.7% |
| 10 | $217.05 | 4,302 | $934K | 5.7% |
| Total | $215.97 avg | 76,088 | $16.4M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |